secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001437749-24-015466
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
----------------------------------------------------------------------------

- Received Nasdaq letter on May 7, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price above $1.00 for 10 consecutive business days (April 23 to May 6, 2024).
- Matter is now closed; no further action required by the company.
- Stock symbol: PIRS, traded on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924015466/0001437749-24-015466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924015466/pirs20240507_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-015466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer